Blueprint Medicines Corp Insider Trading for October 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Blueprint Medicines Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Blueprint Medicines Corp for October 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | M | 8.80 | 3,409 | 29,999 | 0 | |
| Oct 27 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | M | 15.01 | 5,774 | 86,668 | 0 | |
| Oct 27 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Buy | M | 8.80 | 3,409 | 29,999 | 28,147 | 24.7 K to 28.1 K (+13.78 %) |
| Oct 27 2020 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Buy | M | 15.01 | 5,774 | 86,668 | 24,738 | 19 K to 24.7 K (+30.45 %) |
| Oct 21 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 19.53 | 5,455 | 106,536 | 0 | |
| Oct 21 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 105.00 | 5,455 | 572,775 | 3,562 | 9 K to 3.6 K (-60.50 %) |
| Oct 21 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 19.53 | 5,455 | 106,536 | 9,017 | 3.6 K to 9 K (+153.14 %) |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 13,334 | 480,691 | 5,000 | |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 100.55 | 7,200 | 723,960 | 42,838 | 50 K to 42.8 K (-14.39 %) |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 101.56 | 3,125 | 317,375 | 50,038 | 53.2 K to 50 K (-5.88 %) |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 102.53 | 3,009 | 308,513 | 53,163 | 56.2 K to 53.2 K (-5.36 %) |
| Oct 20 2020 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 13,334 | 480,691 | 56,172 | 42.8 K to 56.2 K (+31.13 %) |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 8.80 | 600 | 5,280 | 4,164 | |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 100.00 | 600 | 60,000 | 9,984 | 10.6 K to 10 K (-5.67 %) |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 8.80 | 600 | 5,280 | 10,584 | 10 K to 10.6 K (+6.01 %) |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 5,000 | 44,000 | 42,170 | |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 99.17 | 5,000 | 495,850 | 141,434 | 146.4 K to 141.4 K (-3.41 %) |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 5,000 | 44,000 | 146,434 | 141.4 K to 146.4 K (+3.54 %) |
| Oct 08 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Option Exercise | M | 37.11 | 4,600 | 170,706 | 52,600 | |
| Oct 08 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 99.00 | 4,600 | 455,400 | 15,250 | 19.9 K to 15.3 K (-23.17 %) |
| Oct 08 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Buy | M | 37.11 | 4,600 | 170,706 | 19,850 | 15.3 K to 19.9 K (+30.16 %) |